Clinical Trial Update: T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) [Phase 2]

View source ↗

Summary

The Phase 2 ATEMPT trial comparing trastuzumab emtansine (T-DM1) to paclitaxel plus trastuzumab in breast cancer has completed and results were posted in Januar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Kadcyla (ado-trastuzumab emtansine)
• Taxol (paclitaxel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-01-19